Navigation Links
AACR colorectal cancer conference to focus on screening, new treatments
Date:10/21/2010

PHILADELPHIA The American Association for Cancer Research will hosts its first special conference on Colorectal Cancer: Biology to Therapy from Oct. 27-30, 2010, at the Loews Hotel, Philadelphia.

Colorectal cancer is the third leading cause of cancer in men and women. While screening has brought mortality rates down, much work remains to be done.

"Colorectal cancer is still one of the deadliest cancers, and our current screening methods are not yet always efficient or complete," said Anil Rustgi, M.D., chief of gastroenterology, T. Grier Miller Professor of Medicine and Genetics, and American Cancer Society Professor at the University of Pennsylvania School of Medicine and a program chairperson of the AACR special conference.

Rustgi will host a press conference on Thursday, Oct. 28 at 1:00 p.m. ET in the Adams Room on the third floor of the Loews Hotel in Philadelphia. The press conference will feature the following new research:

  • Telomere Length Affects Colorectal Cancer Risk
  • New Colorectal Screening Test Measures DNA Methylation
  • FAK Inhibitor Effectively Blocked Colon Cancer Cell Growth and Viability
  • Jekyll-Hyde MicroRNA Binding Variant Linked to Improved Outcome in Early-stage Colorectal Cancer

Reporters who cannot attend in person can participate using the following information:

Dial-in (U.S. and Canada): (888) 282-7404
Dial-in (International): (706) 679-5207
Access Code: 18304706

The American Association for Cancer Research Communications Department has also identified the following research as newsworthy:

  • Researchers Build Colony of Colon Cancer Stem Cells to Test New Approach to Therapy
  • Small-molecule Inhibitors Effectively Targeted Active Colon Cancer Enzyme


'/>"/>

Contact: Jeremy Moore
jeremy.moore@aacr.org
267-646-0557
American Association for Cancer Research
Source:Eurekalert

Page: 1

Related biology news :

1. Hormone therapy associated with reduced colorectal cancer risk
2. Rural areas able to increase screening capacity for colorectal cancer
3. Study finds colorectal cancer rates increasing worldwide
4. Colorectal cancer
5. Cigarette smoking increases colorectal cancer risk
6. Breast cancer treatment resistance linked to signaling pathway
7. Jefferson scientists deliver toxic genes to effectively kill pancreatic cancer cells
8. The dietary supplement genistein can undermine breast cancer treatment
9. Saliva proteins could help detection of oral cancer
10. Vitamin C supplements may reduce benefit from wide range of anti-cancer drugs
11. Breakthrough optical technology to assess colon cancer risk, accuracy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2016)... , Nov. 23, 2016 Cercacor today introduced ... and their trainers non-invasively measure hemoglobin, Oxygen ... Rate, and Respiration Rate in approximately 30 seconds. Smaller ... easy and immediate access to key data about their ... a training regimen. Hemoglobin carries oxygen ...
(Date:11/22/2016)... 2016   MedNet Solutions , an innovative SaaS-based ... clinical research, is pleased to announce that the company ... Life Sciences Awards as "Most Outstanding in eClinical ... year of recognition and growth for MedNet, which has ... iMedNet ™ , MedNet,s flagship ...
(Date:11/19/2016)... , Nov. 18, 2016 Securus Technologies, a ... for public safety, investigation, corrections and monitoring, announced today ... competitor, ICSolutions, to have an independent technology judge determine ... most modern high tech/sophisticated telephone calling platform, and the ... that they do most of what we do – ...
Breaking Biology News(10 mins):
(Date:12/6/2016)... ... December 06, 2016 , ... ... largest privately-held contract pharmaceutical development and manufacturing organisation, today announced the ... company combining a leading CRO and the industry’s only Contract Commercial Organization ...
(Date:12/6/2016)... ... December 06, 2016 , ... Clinical Supplies ... has acquired the assets of Theorem Clinical Research - Clinical Supplies ("TCS"). ... trial drug packaging, labeling, storage, reconciliation, and distribution for pharmaceutical trials across ...
(Date:12/6/2016)... 6, 2016  The Texas Medical Center ... (HISA) today announced the establishment of a new ... Australia and the Texas Medical ... HISA and the Texas Medical Center, with ... create a global health innovation ecosystem where emerging technologies ...
(Date:12/5/2016)... Research and Markets has announced the addition of ... to their offering. ... , This report describes ... such as proteomics and metabolomics. Molecular diagnostics technologies are used for ... biomarker. Currently the most important applications of biomarkers are ...
Breaking Biology Technology: